Paper
16 March 2006 Power spectral analysis of mammographic parenchymal patterns
Hui Li, Maryellen L. Giger, Olufunmilayo I. Olopade
Author Affiliations +
Abstract
Mammographic density and parenchymal patterns have been shown to be associated with the risk of developing breast cancer. Two groups of women: gene-mutation carriers and low-risk women were included in this study. Power spectral analysis was performed within parenchymal regions of 172 digitized craniocaudal normal mammograms of the BRCA1/BRCA2 gene-mutation carriers and those of women at low-risk of developing breast cancer. The power law spectrum of the form, P(f)=B/fβ was evaluated for the mammographic patterns. Receiver Operating Characteristic (ROC) analysis was used to assess the performance of exponent β as a decision variable in the task of distinguishing between high and low-risk subjects. Power spectral analysis of mammograms demonstrated that mammographic parenchymal patterns have a power-law spectrum of the form, P(f)=B/fβ where f is radial spatial frequency, with the average β values of 2.92 and 2.47 for the gene-mutation carriers and for the low-risk women, respectively. Az values of 0.90 and 0.89 were achieved in distinguishing between the gene-mutation carriers and the low-risk women with the individual image β value as the decision variable in the entire database and the age-matched group, respectively.
© (2006) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Hui Li, Maryellen L. Giger, and Olufunmilayo I. Olopade "Power spectral analysis of mammographic parenchymal patterns", Proc. SPIE 6144, Medical Imaging 2006: Image Processing, 61445J (16 March 2006); https://doi.org/10.1117/12.654188
Lens.org Logo
CITATIONS
Cited by 1 scholarly publication.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Mammography

Breast

Breast cancer

Databases

Spatial frequencies

Receivers

Cancer

Back to Top